MedTrace Logo

Acute-On-Chronic Liver Failure in Zagazig University Hospitals

NCT03184636 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2018-08-14

No results posted yet for this study

Summary

Rationale:

To identify the prevalence of Acute-on-chronic liver failure in Zagazig University Hospitals.

The question of the research:

How much the prevalence of Acute-on-chronic Liver Failure in Zagazig University Hospitals?

The aim of the work:

The aim of the study is to identify the presence of Acute-on-chronic Liver Failure in Zagazig University Hospitals

Objectives:

To estimate the prevalence of Acute-on-chronic Liver Failure in Zagazig University Hospitals.

Subjects and Methods:

I . Technical Design:

* Site of the study: Gastroenterology and Hepatology Unit- Zagazig University Hospitals
* Sample size: ''all patients admitted to Gastroenterology and Hepatology Unit with the criteria of ACLF according to EASL-AASLD from June 2017 to December 2017 were included in this study''.

II . OPERATIONAL DESIGN:

* Type of the study: a prospective study.
* Full medical history - taking.
* Full clinical examination.
* Laboratory investigations including Routine laboratory investigation " CBC, Liver functions test, kidney functions test and prothrombin time "

III. Administrative Design:

* Approvals obtained for performing the study from the official or governmental department.
* An ethical committee from the faculty of medicine and patients included in the study.

Results:

Collected data will be presented in tables and suitable graphs and analyzed according to standard statistical methods

Conditions

  • Acute-On-Chronic Liver Failure

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-08-11
Completion
2018-08-11

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03184636 on ClinicalTrials.gov